Your browser doesn't support javascript.
loading
Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests.
Yamaoka, Yutaro; Miyakawa, Kei; Jeremiah, Sundararaj Stanleyraj; Funabashi, Rikako; Okudela, Koji; Kikuchi, Sayaka; Katada, Junichi; Wada, Atsuhiko; Takei, Toshiki; Nishi, Mayuko; Shimizu, Kohei; Ozawa, Hiroki; Usuku, Shuzo; Kawakami, Chiharu; Tanaka, Nobuko; Morita, Takeshi; Hayashi, Hiroyuki; Mitsui, Hideaki; Suzuki, Keita; Aizawa, Daisuke; Yoshimura, Yukihiro; Miyazaki, Tomoyuki; Yamazaki, Etsuko; Suzuki, Tadaki; Kimura, Hirokazu; Shimizu, Hideaki; Okabe, Nobuhiko; Hasegawa, Hideki; Ryo, Akihide.
Afiliación
  • Yamaoka Y; Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
  • Miyakawa K; Life Science Laboratory, Technology and Development Division, Kanto Chemical Co., Inc., Isehara, Kanagawa 259-1146, Japan.
  • Jeremiah SS; Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
  • Funabashi R; Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
  • Okudela K; Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
  • Kikuchi S; Department of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
  • Katada J; Life Science Laboratory, Technology and Development Division, Kanto Chemical Co., Inc., Isehara, Kanagawa 259-1146, Japan.
  • Wada A; Medical Systems Research & Development Center, FUJIFILM Corporation, Kaisei, Kanagawa 258-8538, Japan.
  • Takei T; Medical Systems Research & Development Center, FUJIFILM Corporation, Kaisei, Kanagawa 258-8538, Japan.
  • Nishi M; Medical Systems Research & Development Center, FUJIFILM Corporation, Kaisei, Kanagawa 258-8538, Japan.
  • Shimizu K; Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
  • Ozawa H; Yokohama City Institute of Public Health, Yokohama, Kanagawa 236-0051, Japan.
  • Usuku S; Yokohama City Institute of Public Health, Yokohama, Kanagawa 236-0051, Japan.
  • Kawakami C; Yokohama City Institute of Public Health, Yokohama, Kanagawa 236-0051, Japan.
  • Tanaka N; Yokohama City Institute of Public Health, Yokohama, Kanagawa 236-0051, Japan.
  • Morita T; Yokohama City Institute of Public Health, Yokohama, Kanagawa 236-0051, Japan.
  • Hayashi H; Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
  • Mitsui H; Division of Pathology, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa 221-0855, Japan.
  • Suzuki K; Department of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
  • Aizawa D; Life Science Laboratory, Technology and Development Division, Kanto Chemical Co., Inc., Isehara, Kanagawa 259-1146, Japan.
  • Yoshimura Y; Life Science Laboratory, Technology and Development Division, Kanto Chemical Co., Inc., Isehara, Kanagawa 259-1146, Japan.
  • Miyazaki T; Division of Infectious Disease, Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa 221-0855, Japan.
  • Yamazaki E; Department of Physiology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
  • Suzuki T; Clinical Laboratory Department, Yokohama City University Hospital, Yokohama, Kanagawa 236-0004, Japan.
  • Kimura H; Department of Pathology, National Institute of Infectious Diseases, Shinjuku, Tokyo 162-8640, Japan.
  • Shimizu H; School of Medical Technology, Faculty of Health Sciences, Gunma Paz University, Takasaki, Gunma 370-0006, Japan.
  • Okabe N; Division of Virology, Kawasaki City Institute for Public Health, Kawasaki, Kanagawa 210-0821, Japan.
  • Hasegawa H; Division of Virology, Kawasaki City Institute for Public Health, Kawasaki, Kanagawa 210-0821, Japan.
  • Ryo A; Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases, Musashimurayama, Tokyo 208-0011, Japan.
Cell Rep Med ; 2(6): 100311, 2021 06 15.
Article en En | MEDLINE | ID: mdl-34027498
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoensayo / Proteínas de la Nucleocápside de Coronavirus / SARS-CoV-2 / Anticuerpos Monoclonales / Epítopos Tipo de estudio: Diagnostic_studies Límite: Animals / Humans Idioma: En Revista: Cell Rep Med Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoensayo / Proteínas de la Nucleocápside de Coronavirus / SARS-CoV-2 / Anticuerpos Monoclonales / Epítopos Tipo de estudio: Diagnostic_studies Límite: Animals / Humans Idioma: En Revista: Cell Rep Med Año: 2021 Tipo del documento: Article País de afiliación: Japón